Exome Asset Management »

Inari Medical Ord shares owned by Exome Asset Management

Quarter-by-quarter ownership of Inari Medical Ord (NARI) shares owned by Exome Asset Management from 13F filings

Historical chart of Exome Asset Management investment in Inari Medical Ord

Tip: Access up to 7 years of quarterly data

All positions including Inari Medical Ord held by Exome Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Inari Medical Ord by Exome Asset Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.4M 30k 47.98

More positions owned by Exome Asset Management

Eli Lilly & Co. (LLY)
Dr Reddys Labs Adr (RDY)
Beigene Sponsored Adr (BGNE)
Cigna Corp (CI)
Alpine Immune Sciences (ALPN)
Tg Therapeutics (TGTX)
Avidity Biosciences Ord (RNA)
Corbus Pharmaceuticals Hldgs Com New (CRBP)
Dex (DXCM)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
Celldex Therapeutics Com New (CLDX)
Geron Corporation (GERN)
Aerovate Therapeutics (AVTE)
Morphosys Sponsored Ads (MOR)
Travere Therapeutics (TVTX)

View all positions for Exome Asset Management

Top funds holding Inari Medical Ord

BlackRock
Vanguard Group
Wellington Management Company
HCC Manager
Franklin Resources
Millennium Management
Alliancebernstein
Brown Advisory Holdings Incorporated
Morgan Stanley
Credit Suisse
Geode Capital Management
Jpmorgan Chase & Co
Eventide Asset Management
Ing Investment Management
Bamco

View all funds holding Inari Medical Ord